The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

Table 1

Patient demographics.

FAS group ()	Mean ± SD	Median	Range
Gender (men, %)	11 (100)
Age (years)	47.7 ± 10.1	46	32–64
Height (cm)	170.1 ± 6.9	170	160.8–184.6
Weight (kg)	71.4 ± 6.5	70.4	58.0–79.0
Duration of IBS (year)	9.6 ± 9.0	8	0.5–30
Past history of GI surgery, no. (%)	1 (9.1)
Smoking status, no. (%)
Nonsmoker	2 (18.2)
Ex-smoker	4 (36.4)
Current smoker	5 (45.5)
Alcohol intake, no. (%)
Never	3 (27.3)
Previously	2 (18.2)
Current	6 (54.5)
Exercise, no. (%)
Yes	8 (72.7)
No	3 (27.3)

FAS: full analysis set; IBS: irritable bowel syndrome; GI: gastrointestinal; SD: standard deviation.